From Lab to Boardroom at Sartorius
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with René, covering:
How a lucky break brought him to Sartorius over 20 years ago, and what has changed and stayed the same over that time
His journey from scientist to senior leader, and the evolution of biologics he has witnessed along the way
The pace of innovation in bioprocessing, and how he thinks about speed, efficiency and flexibility
Why innovation continues regardless of market cycles, through both boom and correction periods
His perspective on the current biotech market reset and why it represents a healthy correction
Despite building a €3.5bn powerhouse, how Sartorius has maintained a relentless focus on customers
René Fáber, born in 1975, has been Head of Bioprocess Solutions Division and Member of the Executive Board of Sartorius AG since 2019. In the same year, he became a Member of the Board of Directors of Sartorius Stedim Biotech S.A.; in 2023 he was appointed as CEO of the company. René Fáber studied chemistry in Bratislava, Slovakia, and earned his Ph.D. in polymer chemistry from the Technical University of Munich in Germany. He joined Sartorius in 2002, where he initially worked as a scientist on membrane modification. As Vice President, he held various management positions in R&D, Marketing for Filtration and Fermentation Technologies, as well as in Key Account Management. In his most recent position, he was responsible for the Product Development unit of the Bioprocess Solutions Division.
Molecule to Market is also sponsored by Bora Pharmaceuticals, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
How a lucky break brought him to Sartorius over 20 years ago, and what has changed and stayed the same over that time
His journey from scientist to senior leader, and the evolution of biologics he has witnessed along the way
The pace of innovation in bioprocessing, and how he thinks about speed, efficiency and flexibility
Why innovation continues regardless of market cycles, through both boom and correction periods
His perspective on the current biotech market reset and why it represents a healthy correction
Despite building a €3.5bn powerhouse, how Sartorius has maintained a relentless focus on customers
René Fáber, born in 1975, has been Head of Bioprocess Solutions Division and Member of the Executive Board of Sartorius AG since 2019. In the same year, he became a Member of the Board of Directors of Sartorius Stedim Biotech S.A.; in 2023 he was appointed as CEO of the company. René Fáber studied chemistry in Bratislava, Slovakia, and earned his Ph.D. in polymer chemistry from the Technical University of Munich in Germany. He joined Sartorius in 2002, where he initially worked as a scientist on membrane modification. As Vice President, he held various management positions in R&D, Marketing for Filtration and Fermentation Technologies, as well as in Key Account Management. In his most recent position, he was responsible for the Product Development unit of the Bioprocess Solutions Division.
Molecule to Market is also sponsored by Bora Pharmaceuticals, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Loading content...
Read the full transcript
Matterfact has every podcast on Apple Podcasts and Spotify: 700K+ channels, 120M+ episodes.
The candid version is on a podcast,
not the earnings call.
Matterfact turns the conversations your coverage is already having into a searchable, citable record — across every episode, not just this one.